AllianceBernstein
BLU

AllianceBernstein’s BELLUS Health Inc. BLU Stock Holding History

AllianceBernstein’s Portfolio BLU Stock Details BLU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-218,601
Closed -$2.31M – 3318
2022
Q3 		$2.31M Buy
218,601
+78,427
+56% +$833K ﹤0.01% 1797
2022
Q2 		$1.29M Buy
+140,174
New +$1.15M ﹤0.01% 2201

Other funds holding BLU

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
PCOC
Power Corp of Canada Montreal, Quebec, Canada $745M AUM 22.7% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

AllianceBernstein's BLU Position: Q4 2022 in Review

AllianceBernstein sold out of BELLUS Health Inc. (BLU) in Q4 2022, closing a stake of 218,601 shares — an estimated $2.31M sold.

AllianceBernstein first reported a position in BLU in Q2 2022 and held it in 2 quarters. The position peaked at $2.31M in Q3 2022. 121 funds tracked by Wall St. Rank hold BLU as of Q4 2022.

  • AllianceBernstein reported no remaining BELLUS Health Inc. position as of Q4 2022 after selling out during the quarter.
  • AllianceBernstein sold 218,601 BELLUS Health Inc. shares in Q4 2022, an estimated $2.31M.
  • AllianceBernstein first reported a position in BELLUS Health Inc. in Q2 2022 and held it in 2 quarters.
  • AllianceBernstein's BELLUS Health Inc. position peaked at $2.31M in Q3 2022.
  • 121 funds tracked by Wall St. Rank held BELLUS Health Inc. as of Q4 2022.

Based on AllianceBernstein's 13F filing for Q4 2022, filed 15 Feb 2023.